Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Langer Robert
Relationship:   Director
City:   Newton
State:   MA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   23,176,520    

Indirect Shares

   68,091      
Direct Value   $55,092,361    

Indirect Value

   $0      
Total Shares   23,244,611      
Total Value   $55,092,361      


Momenta Pharmaceuticals Inc $49,857,155 Echo Therapeutics Inc $121 Invivo Therapeutics Holdings Corporation $2,899,115 DNIB Upwind Inc $0 Selecta Biosciences Inc $230,678 Kala Pharmaceuticals, Inc. $2,105,293 Moderna, Inc. $0 Korro Bio $0 Lyra Therapeutics, Inc. $0 Sqz Biotechnologies Co $0 Seer, Inc. $0 Momenta Pharmaceuticals Inc $49,857,155 Echo Therapeutics Inc $121 Invivo Therapeutics Holdings Corporation $2,899,115 DNIB Upwind Inc $0 Selecta Biosciences Inc $230,678 Kala Pharmaceuticals, Inc. $2,105,293 Moderna, Inc. $0 Korro Bio $0 Lyra Therapeutics, Inc. $0 Sqz Biotechnologies Co $0 Seer, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2008-08-08 950,022 0    Premium*  
            Echo Therapeutics Inc ECTE Director 2009-12-11 603,450 2004-05-26 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV 10% Owner 2013-06-05 7,433,628 0    Premium*  
            DNIB Upwind Inc BIND Director 2016-08-26 738,424 0    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-21 457,603 0    Premium*  
            Kala Pharmaceuticals, Inc. KALA Director, 10% Owner 2017-07-19 326,402 0    Premium*  
            Moderna, Inc. MRNA Director 2022-04-28 11,467,664 2022-04-28 42,396    Premium*  
            Rubius Therapeutics, Inc. RUBY Director 2019-10-14 0 2019-01-14 0    Premium*  
            Korro Bio KRRO Director 2020-11-17 214,326 2020-11-17 25,695    Premium*  
            Lyra Therapeutics, Inc. LYRA Director 2020-05-05 15,167 0    Premium*  
            Sqz Biotechnologies Co SQZ 10% Owner 2020-10-29 243,987 0    Premium*  
            Seer, Inc. SEER Director 2023-06-14 725,847 0    Premium*  
* Premium Members only  

Records found :    76         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-02 4 AS $3.05 $7,625 D/D (2,500) 7,488,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-03 4 AS $3.02 $7,551 D/D (2,500) 7,486,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-06 4 AS $3.00 $7,510 D/D (2,500) 7,483,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-07 4 AS $2.94 $7,338 D/D (2,500) 7,481,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-08 4 AS $2.86 $7,145 D/D (2,500) 7,478,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-09 4 AS $2.94 $7,338 D/D (2,500) 7,476,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-10 4 AS $2.89 $7,237 D/D (2,500) 7,473,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-13 4 AS $3.00 $7,500 D/D (2,500) 7,471,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-14 4 AS $2.85 $7,125 D/D (2,500) 7,468,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-15 4 AS $2.85 $7,115 D/D (2,500) 7,466,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-16 4 AS $2.84 $7,090 D/D (2,500) 7,463,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-17 4 AS $2.86 $7,157 D/D (2,500) 7,461,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-20 4 AS $2.88 $7,210 D/D (2,500) 7,458,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-21 4 AS $2.87 $7,180 D/D (2,500) 7,456,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-22 4 AS $2.89 $7,220 D/D (2,500) 7,453,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-23 4 AS $2.90 $7,250 D/D (2,500) 7,451,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-24 4 AS $2.97 $7,420 D/D (2,500) 7,448,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-28 4 AS $3.03 $7,570 D/D (2,500) 7,446,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-29 4 AS $3.13 $7,825 D/D (2,500) 7,443,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-30 4 AS $3.40 $8,500 D/D (2,500) 7,441,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-05-31 4 AS $3.39 $8,475 D/D (2,500) 7,438,878 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-06-03 4 AS $3.37 $8,432 D/D (2,500) 7,436,378 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-06-04 4 AS $3.90 $9,754 D/D (2,500) 7,436,128 0 -
NVIV Invivo Therapeutics Holdi... 10% Owner   –       –       •   2013-06-05 4 AS $3.91 $9,775 D/D (2,500) 7,433,628 0 -
BIND DNIB Upwind Inc Director   –       •      –    2016-08-26 4 OE $0.44 $6,600 D/D 15,000 738,424 0 -
  76  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us